Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-23

Clinical Trial Update: A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol [Phase 2]

View source ↗

Summary

Phase 2 randomized trial assessing potential drug-drug interactions between clobazam and cannabidiol in epilepsy; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBAZAM (CLOBAZAM)
  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2018-08-23